Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

JAK inhibitors do not improve hair regrowth in androgenic alopecia but may prevent further hair loss.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

JAK inhibitors show promise for treating various skin diseases.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

JAK inhibitors offer new hope for treating severe alopecia areata.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

JAK inhibitors can enter the skin through hair follicles using a unique pathway.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

The name Janus is fitting for JAK inhibitors as they revolutionize dermatology treatments.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Combination therapy effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Deucravacitinib helped a man regrow hair significantly.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.